134 results
8-K
TXMD
TherapeuticsMD Inc
5 Dec 22
TherapeuticsMD Announces Definitive Agreements to License its Products to Mayne Pharma
7:31am
the initial $140.0 million payment to the Company from cash and existing debt facilities and through a binding commitment from Rubric Capital Management
8-K
EX-10.2
4k3ikfsvpgvltb2r0r44
31 Oct 22
TherapeuticsMD Announces Additional $7 Million Private Placement
7:00am
8-K
EX-10.1
1got4
31 Oct 22
TherapeuticsMD Announces Additional $7 Million Private Placement
7:00am
8-K
EX-10.1
fs6ag5e
3 Oct 22
TherapeuticsMD Announces $7 Million Private Placement
7:00am
8-K
EX-10.2
kxhf8tdyollj tncttv
3 Oct 22
TherapeuticsMD Announces $7 Million Private Placement
7:00am
8-K
EX-10.2
dly0np3n cytoje
1 Aug 22
TherapeuticsMD Secures $15 Million Equity Investment from Rubric Capital
6:55am
8-K
EX-10.1
00jjzvcb
1 Aug 22
TherapeuticsMD Secures $15 Million Equity Investment from Rubric Capital
6:55am
SC TO-T/A
t5g215gkk 0abn
6 Jul 22
Third party tender offer statement (amended)
6:23am
SC TO-T/A
EX-99
hllphmp
6 Jul 22
Third party tender offer statement (amended)
6:23am
SC 14D9
z9j7 ilqatz98p
10 Jun 22
Tender offer solicitation
6:51pm
SC TO-T
8ikds mtxiiwbq
6 Jun 22
Third party tender offer statement
5:02pm
SC TO-T
EX-99
zx00nzh2hmrdez584
6 Jun 22
Third party tender offer statement
5:02pm
SC TO-T
EX-99
pyz0oioo al
6 Jun 22
Third party tender offer statement
5:02pm
SC TO-T
EX-99
s4d6zp mper3x3fh
6 Jun 22
Third party tender offer statement
5:02pm